Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Assembly Biosciences (ASMB) over the last 16 years, with Dec 2024 value amounting to $129,000.

  • Assembly Biosciences' Depreciation & Amortization (CF) fell 3.03% to $32,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $129,000, marking a year-over-year decrease of 28.73%. This contributed to the annual value of $129,000 for FY2024, which is 71.33% down from last year.
  • As of FY2024, Assembly Biosciences' Depreciation & Amortization (CF) stood at $129,000, which was down 71.33% from $450,000 recorded in FY2023.
  • Assembly Biosciences' 5-year Depreciation & Amortization (CF) high stood at $691,000 for FY2020, and its period low was $129,000 during FY2024.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $450,000 (2023), whereas its average is $359,000.
  • As far as peak fluctuations go, Assembly Biosciences' Depreciation & Amortization (CF) skyrocketed by 39.88% in 2020, and later tumbled by 71.33% in 2024.
  • Over the past 5 years, Assembly Biosciences' Depreciation & Amortization (CF) (Yearly) stood at $691,000 in 2020, then tumbled by 32.56% to $466,000 in 2021, then increased by 6.87% to $498,000 in 2022, then declined by 9.64% to $450,000 in 2023, then plummeted by 71.33% to $129,000 in 2024.